June 21, 2001Open Access

Deep Venous Thrombosis and Thalidomide Therapy for Multiple Myeloma

KOKeren OsmanIcahn School of Medicine at Mount Sinai RCRaymond L. ComenzoTufts University

S. Vincent RajkumarUniversity of Maryland, Baltimore

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

To the Editor: Thalidomide is effective for the treatment of refractory myeloma.1 Its role in the initial treatment of the disease is under active investigation.2,3 We report the occurrence of deep...

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo

Cite This Study

Osman et al. (Thu,) studied this question.

synapsesocial.com/papers/6a583fe7d848c9ced74cc866 https://doi.org/https://doi.org/10.1056/nejm200106213442516

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1[Thalidomide and thrombosis].2000 · 51 citations
2Antitumor Activity of Thalidomide in Refractory Multiple Myeloma1999 · 2,594 citations
3Life-Threatening Toxic Epidermal Necrolysis with Thalidomide Therapy for Myeloma2000 · 100 citations
4Relapse of multiple myeloma after autologous transplantation: survival after salvage therapy.1995 · 85 citations
5Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes.1991 · 1,203 citations

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo